U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry MIXED
Molecular Formula C25H29NO2.H3O4P
Molecular Weight 473.4984
Optical Activity UNSPECIFIED
Defined Stereocenters 0 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIFETEROL PHOSPHATE

SMILES

OP(O)(O)=O.CC(C(O)C1=CC=CC=C1)N(C)CCOC(C2=CC=CC=C2)C3=CC=CC=C3

InChI

InChIKey=GZECPKFYQHSCEV-UHFFFAOYSA-N
InChI=1S/C25H29NO2.H3O4P/c1-20(24(27)21-12-6-3-7-13-21)26(2)18-19-28-25(22-14-8-4-9-15-22)23-16-10-5-11-17-23;1-5(2,3)4/h3-17,20,24-25,27H,18-19H2,1-2H3;(H3,1,2,3,4)

HIDE SMILES / InChI

Description
Curator's Comment: Description was created based on several sources, including http://www.google.com/patents/US20040259955

Antihistamine agent

Approval Year

Targets

Targets

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown

Sample Use Guides

A daily combination dosage of difeterol hydrochloride and difeterol phosphate for an adult is usually between 5 and 180 mg, preferably between 10 and 135 mg, more preferably between 18 and 90 mg.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
DIFETEROL PHOSPHATE
JAN  
Common Name English
DIFETEROL PHOSPHATE [JAN]
Common Name English
DIFETEROL MONOPHOSPHATE
Common Name English
BENZENEMETHANOL, .ALPHA.-(1-((2-(DIPHENYLMETHOXY)ETHYL)METHYLAMINO)ETHYL)-, PHOSPHATE (SALT)
Common Name English
Code System Code Type Description
FDA UNII
9F8714PSRG
Created by admin on Sat Dec 16 06:18:23 GMT 2023 , Edited by admin on Sat Dec 16 06:18:23 GMT 2023
PRIMARY
PUBCHEM
53297470
Created by admin on Sat Dec 16 06:18:23 GMT 2023 , Edited by admin on Sat Dec 16 06:18:23 GMT 2023
PRIMARY
CAS
866550-55-2
Created by admin on Sat Dec 16 06:18:23 GMT 2023 , Edited by admin on Sat Dec 16 06:18:23 GMT 2023
NON-SPECIFIC STOICHIOMETRY